Pharmacokinetics and effects on the renin-angiotensin system of ramipril in elderly patients

References

Page 1

	Year	Citations
MORTALITY AND MORBIDITY RESULTS FROM THE EUROPEAN WORKING PARTY ON HIGH BLOOD PRESSURE IN THE ELDERLY TRIAL1, 2 A. Amery The Lancet HypertensionAgingHealth PolicyGeriatricsCardiovascular Epidemiology	1985	1.5K
Influence of range of renal function and liver disease on predictability of creatinine clearance J. Heyward Hull, Lawrence J. Hak, Gary G. Koch, Clinical Pharmacology & Therapeutics HemodialysisUrologyDrug DosagesHepatologyRenal Function	1981	158
A micro assay for active and total renin concentration in human plasma based on antibody trapping J. A. Millar, B Leckie, J J Morton, Clinica Chimica Acta MedicineBioanalysisMass SpectrometryImmunologyPharmacology	1980	137
Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition. A. B. Atkinson, John J. Morton, J. J. Brown, Heart Molecular PharmacologyHypertensionRenal FunctionAngiotensin IiCardiovascular Disease	1980	71
Hormones in human blood, detection and assay J Robbins Trends in Biochemical Sciences Endocrine MechanismBioanalysisGynecologyHuman BloodClinical Chemistry	1977	60
The effect of the converting enzyme inhibitor HOE 498 on the renin angiotensin system of normal volunteers J. P. Bussien, J. Nussberger, M Porchet, Naunyn-Schmiedeberg s Archives of Pharmacology Molecular PharmacologyHypertensionRenin Angiotensin SystemCardiovascular DiseaseMedicine	1985	29
A dose‐response study of HOE 498, a new non‐sulphydryl converting enzyme inhibitor, on blood pressure, pulse rate and the renin‐ angiotensin‐aldosterone system in normal man. P.J.O Manhem, JJ Morton, B.J. Leckie, British Journal of Clinical Pharmacology	1985	29
Tolerance and pharmacodynamics of the angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) in healthy volunteers. Witte Pu, H. Metzger, Eckert Hg, PubMed HypertensionPlasma AceCardiovascular PharmacologyPharmacotherapyNephrology	1984	21
Determination of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) and its hydrolysis product in serum and urine. Péter Hajdú, Douglass Schmidt, M. Bomm, PubMed Pharmaceutical SciencePharmaceutical ChemistryPharmacokineticsMedicinal ChemistryBioanalysis	1984	16

Page 1